文献速递外周动脉疾病

衰弱慢性肢体威胁性缺血患者姑息性肢体治疗的15年单中心经验

A single center's 15-year experience with palliative limb care for chronic limb threatening ischemia in frail patients.
PubMed 文献 · J Vasc Surg · 2021-10-08

该研究分析了2005至2020年纳入PAVE项目的157条接受姑息性肢体治疗的CLTI肢体(145例患者),总体死亡率为88.2%(中位3.5个月),仅11.5%最终截肢,20.6%伤口愈合,提示衰弱CLTI患者早期死亡风险高而肢体相关并发症风险低。

要点

  • 衰弱CLTI患者接受姑息性肢体治疗的中位生存仅3.5个月,总体死亡率达88.2%。
  • 该组患者30天肢体相关再入院率为4.7%,最终大截肢率仅11.5%。
  • WIfI评分与肢体相关入院显著相关(r=0.97),但与死亡无关。

核心结论

  • 衰弱CLTI患者接受姑息性肢体治疗早期死亡率高但肢体相关并发症风险低。
  • 绝大多数患者在入组后数月内死亡且未需要截肢。
  • CLTI综合治疗应包括姑息性肢体治疗选项以避免不必要的手术和大截肢。

研究设计与样本

  • 单中心前瞻性队列研究,分析2005年1月至2020年1月纳入PAVE项目的157条肢体(145例患者),主要结局为死亡率。

主要发现

  • 总体死亡率为88.2%,中位死亡间隔3.5个月(范围0-91个月)。
  • 128例死亡患者中64例(50%)在入组3个月内死亡。
  • 预估5年死亡率为66%,平均CFS评分为6.2(中度至重度衰弱)。
  • 30天肢体相关再入院率为4.7%,18条肢体(11.5%)最终需大截肢,30例患者(20.6%)伤口愈合。
  • 衰弱与非衰弱患者死亡率无差异,但早期(<3个月)死亡率差异有统计学意义(56.2% vs 37.5%;P = .032)。

关键数值与推荐

  • PAVE项目将CLTI患者分配至立即血运重建、保守治疗、一期截肢或姑息性肢体治疗,符合全球CLTI管理指南。
  • 姑息性肢体治疗组平均CFS评分为6.2,106例被认为衰弱、39例非衰弱。

临床怎么用

  • 对衰弱CLTI患者,姑息性肢体治疗可作为综合治疗选项,避免不必要手术和大截肢。
  • WIfI评分可用于预测肢体相关入院风险,但不能预测死亡。

局限性

  • 单中心回顾性分析,样本量有限(145例患者),仅纳入退伍军人人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Our institution's multidisciplinary Prevention of Amputation in Veterans Everywhere (PAVE) program allocates veterans with critical limb threatening ischemia (CLTI) to immediate revascularization, conservative care, primary amputation, or palliative limb care according to previously reported criteria. These four groups align with the approaches outlined by the global guidelines for the management of CLTI. In the present study, we have delineated the natural history of the palliative limb care group of patients and quantified the procedural risks and outcomes. METHODS: Veterans prospectively enrolled into the palliative limb cohort of our PAVE program from January 2005 to January 2020 were analyzed. The primary outcome was mortality. The secondary outcomes included overall and limb-related readmissions, limb loss, and wound healing. The clinical frailty scale (CFS) score was calculated, and the 5-year expected mortality was estimated using the Veterans Affairs Quality Enhancement Research Initiative tool. Regression analysis was performed to establish associations among the following variables: mortality, wound, ischemia, and foot infection (WIfI) score, CFS score, overall admissions, and limb-related admissions. RESULTS: The PAVE program enrolled 1158 limbs during 15 years. Of the 1158 limbs, 157 (13.5%) in 145 patients were allocated to the palliative limb care group. The overall mortality of the group was 88.2% (median interval, 3.5 months; range, 0-91 months). Of the 128 patients who had died, 64 (50%) had died within 3 months of enrollment. The predicted 5-year mortality for the group was 66%. The average CFS score for the group was 6.2, denoting persons moderately to severely frail. Using the CFS score, 106 patients were considered frail and 39 were considered not frail. No differences were found in mortality between the frail and nonfrail patients. However, a statistically significant difference was found in early (<3 months) mortality (56.2% vs 37.5%; P = .032). The 30-day limb-related readmission rate was 4.7%. Eventual major amputation was necessary for 18 limbs (11.5%). Wound healing occurred in 30 patients (20.6%). Regression analysis demonstrated no association between the CFS score and mortality (r = 0.55; P = .159) or between the WIfI score and mortality (r = 0.0165; P = .98). However, a significant association was found between the WIfI score and limb-related admissions (r = 0.97; P < .001). CONCLUSIONS: Frail patients with CLTI had high early mortality and a low risk of limb-related complications. They also had a low incidence of deferred primary amputation or limb-related readmissions. In our cohort, the vast majority of patients had died within a few months of enrollment without requiring an amputation. A comprehensive approach to the treatment of CLTI patients should include a palliative limb care option because a significant proportion of these patients will have limited survival and can potentially avoid unnecessary surgery and major amputation.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Sibona A, Bianchi C, Leong B, et al. A single center's 15-year experience with palliative limb care for chronic limb threatening ischemia in frail patients. J Vasc Surg. 2021. PMID: 34627958. doi:10.1016/j.jvs.2021.09.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。